12:00 AM
 | 
Oct 01, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Dara BioSciences sales and marketing update

Dara said it will launch breast cancer drug Soltamox tamoxifen in the U.S. in mid-October. Dara acquired exclusive, U.S. marketing rights to the product through its January acquisition of...

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >